US Stock MarketDetailed Quotes

INVO INVO Bioscience

Watchlist
  • 0.8906
  • +0.0006+0.07%
Trading May 28 15:33 ET
3.39MMarket Cap-614P/E (TTM)

INVO Bioscience Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
(Q3)Sep 30, 2022
(Q2)Jun 30, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
77.31%-260.56K
27.99%-4.76M
28.81%-714.88K
24.33%-1.25M
12.20%-1.64M
44.74%-1.15M
-9.51%-6.6M
33.55%-1M
-2.40%-1.65M
-59.56%-1.87M
Net income from continuing operations
37.41%-1.6M
26.24%-8.03M
27.91%-1.99M
51.03%-1.25M
20.03%-2.24M
8.05%-2.55M
-63.68%-10.89M
-2,952.08%-2.77M
-2.75%-2.55M
-54.17%-2.8M
Operating gains losses
1,924.73%561.56K
11.46%223.55K
2,013.04%191.44K
-61.98%8.16K
-103.21%-3.79K
-61.00%27.74K
19.08%200.56K
-104.68%-10.01K
-80.83%21.47K
--117.98K
Depreciation and amortization
1,089.08%226.96K
159.89%200.89K
610.12%141.6K
3.91%20.5K
156.60%19.71K
-73.65%19.09K
-53.46%77.3K
-74.87%19.94K
-57.49%19.73K
-209.99%-34.82K
Other non cash items
-78.29%48.49K
421.38%900.13K
56.56%152.87K
691.47%356.16K
--167.72K
--223.38K
-85.47%172.64K
-43.67%97.64K
-42.18%45K
----
Change In working capital
-53.26%285.11K
-68.17%471.7K
-52.77%524.67K
-309.72%-649.17K
-105.56%-13.78K
427.82%609.98K
141.10%1.48M
136.14%1.11M
171.27%309.55K
238.51%247.68K
-Change in receivables
-60.99%-36.34K
-137.64%-63.4K
-307.14%-23.77K
-182.43%-41.87K
1,010.16%24.81K
-173.59%-22.57K
7.27%-26.68K
-860.16%-5.84K
-861.48%-14.83K
-99.53%2.24K
-Change in inventory
73.39%-1.95K
-103.74%-905
-162.24%-10.29K
1,283.27%25.8K
-172.01%-9.1K
-6.69%-7.32K
207.90%24.17K
531.60%16.53K
104.71%1.87K
-28.07%12.64K
-Change in prepaid assets
-444.03%-330.1K
-566.88%-432.09K
-323.63%-257.07K
116.51%9.49K
-534.93%-123.84K
-211.19%-60.68K
174.15%92.55K
333.88%114.95K
-483.20%-57.47K
82.16%-19.5K
-Change in payables and accrued expense
-29.26%546.52K
15.56%1.05M
-27.43%478.6K
-67.49%72.35K
-5,914.38%-277K
4,011.92%772.59K
570.71%905.62K
872.40%659.48K
-0.46%222.58K
102.18%4.76K
-Change in other current liabilities
114.10%2.32K
-2,112.20%-141.38K
2,539.82%28.64K
-13,462.99%-171.85K
-98.74%744
101.99%1.09K
113.05%7.03K
103.31%1.09K
107.55%1.29K
4,007.09%59.06K
-Change in other working capital
243.11%104.66K
-86.87%62.93K
-4.97%308.55K
-447.90%-543.09K
96.61%370.6K
61.49%-73.13K
113.65%479.36K
111.16%324.68K
335.39%156.11K
295.73%188.49K
Cash from discontinued investing activities
Operating cash flow
77.31%-260.56K
27.99%-4.76M
28.81%-714.88K
24.33%-1.25M
12.20%-1.64M
44.74%-1.15M
-9.51%-6.6M
33.55%-1M
-2.40%-1.65M
-59.56%-1.87M
Investing cash flow
Cash flow from continuing investing activities
-185.40%-24.11K
-2,971.87%-2.49M
287.86%33.29K
-74,973.70%-2.26M
-5,234.66%-261.51K
89.68%-8.45K
96.23%-81.22K
100.94%8.58K
99.06%-3.01K
99.19%-4.9K
Net PPE purchase and sale
---24.11K
-4,023.52%-444.72K
-55,655.56%-75K
-4,091.21%-108.22K
-9,643.11%-261.51K
--0
97.41%-10.79K
-99.96%135
99.65%-2.58K
---2.68K
Net intangibles purchase and sale
----
--0
--0
--0
----
----
95.01%-1.94K
--0
86.51%-426
90.52%-607
Net business purchase and sale
--0
-2,893.41%-2.05M
1,181.84%108.29K
---2.15M
--0
88.79%-8.45K
95.97%-68.49K
100.58%8.45K
--0
99.82%-1.61K
Cash from discontinued investing activities
Investing cash flow
-185.40%-24.11K
-2,971.87%-2.49M
287.86%33.29K
-74,973.70%-2.26M
-5,234.66%-261.51K
89.68%-8.45K
96.23%-81.22K
100.94%8.58K
99.06%-3.01K
99.19%-4.9K
Financing cash flow
Cash flow from continuing financing activities
-83.80%527.37K
578.31%7.39M
-117.69%-141.53K
17,753.12%4.45M
-169.86K
933.34%3.26M
-71.10%1.09M
-76.48%800K
-25.2K
0
Net issuance payments of debt
-94.97%27.37K
108.11%1.66M
-117.69%-141.53K
--1.45M
---190.15K
--544K
420.00%800K
--800K
--0
--0
Net common stock issuance
--0
1,867.55%5.7M
---23.05K
11,989.13%3M
--20.3K
759.89%2.71M
-92.06%289.8K
--0
---25.2K
--0
Net preferred stock issuance
--500K
----
----
----
----
--0
----
----
----
----
Proceeds from stock option exercised by employees
--0
--25.43K
--23.05K
--0
---1
--2.38K
--0
--0
--0
--0
Cash from discontinued financing activities
Financing cash flow
-83.80%527.37K
578.31%7.39M
-117.69%-141.53K
17,753.12%4.45M
---169.86K
933.34%3.26M
-71.10%1.09M
-76.48%800K
---25.2K
--0
Net cash flow
Beginning cash position
157.86%232.42K
-98.41%90.14K
269.46%1.06M
-94.27%112.49K
-43.01%2.19M
-98.41%90.14K
-43.70%5.68M
-93.94%285.7K
-70.46%1.96M
-54.41%3.84M
Current changes in cash
-88.43%242.7K
102.54%142.29K
-320.90%-823.12K
156.25%943.06K
-10.55%-2.08M
213.72%2.1M
-26.78%-5.59M
-120.12%-195.56K
13.13%-1.68M
-5.48%-1.88M
End cash Position
-78.29%475.13K
157.86%232.42K
157.86%232.42K
269.46%1.06M
-94.27%112.49K
-43.01%2.19M
-98.41%90.14K
-98.41%90.14K
-93.94%285.7K
-70.46%1.96M
Free cash flow
72.99%-310.26K
21.41%-5.2M
21.33%-789.88K
17.91%-1.36M
-1.59%-1.91M
44.91%-1.15M
-2.03%-6.62M
15.13%-1M
29.94%-1.65M
-58.97%-1.88M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
Unqualified Opinion with Explanatory Notes
--
--
--
--
Unqualified Opinion with Explanatory Notes
--
--
--
(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022(Q3)Sep 30, 2022(Q2)Jun 30, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities 77.31%-260.56K27.99%-4.76M28.81%-714.88K24.33%-1.25M12.20%-1.64M44.74%-1.15M-9.51%-6.6M33.55%-1M-2.40%-1.65M-59.56%-1.87M
Net income from continuing operations 37.41%-1.6M26.24%-8.03M27.91%-1.99M51.03%-1.25M20.03%-2.24M8.05%-2.55M-63.68%-10.89M-2,952.08%-2.77M-2.75%-2.55M-54.17%-2.8M
Operating gains losses 1,924.73%561.56K11.46%223.55K2,013.04%191.44K-61.98%8.16K-103.21%-3.79K-61.00%27.74K19.08%200.56K-104.68%-10.01K-80.83%21.47K--117.98K
Depreciation and amortization 1,089.08%226.96K159.89%200.89K610.12%141.6K3.91%20.5K156.60%19.71K-73.65%19.09K-53.46%77.3K-74.87%19.94K-57.49%19.73K-209.99%-34.82K
Other non cash items -78.29%48.49K421.38%900.13K56.56%152.87K691.47%356.16K--167.72K--223.38K-85.47%172.64K-43.67%97.64K-42.18%45K----
Change In working capital -53.26%285.11K-68.17%471.7K-52.77%524.67K-309.72%-649.17K-105.56%-13.78K427.82%609.98K141.10%1.48M136.14%1.11M171.27%309.55K238.51%247.68K
-Change in receivables -60.99%-36.34K-137.64%-63.4K-307.14%-23.77K-182.43%-41.87K1,010.16%24.81K-173.59%-22.57K7.27%-26.68K-860.16%-5.84K-861.48%-14.83K-99.53%2.24K
-Change in inventory 73.39%-1.95K-103.74%-905-162.24%-10.29K1,283.27%25.8K-172.01%-9.1K-6.69%-7.32K207.90%24.17K531.60%16.53K104.71%1.87K-28.07%12.64K
-Change in prepaid assets -444.03%-330.1K-566.88%-432.09K-323.63%-257.07K116.51%9.49K-534.93%-123.84K-211.19%-60.68K174.15%92.55K333.88%114.95K-483.20%-57.47K82.16%-19.5K
-Change in payables and accrued expense -29.26%546.52K15.56%1.05M-27.43%478.6K-67.49%72.35K-5,914.38%-277K4,011.92%772.59K570.71%905.62K872.40%659.48K-0.46%222.58K102.18%4.76K
-Change in other current liabilities 114.10%2.32K-2,112.20%-141.38K2,539.82%28.64K-13,462.99%-171.85K-98.74%744101.99%1.09K113.05%7.03K103.31%1.09K107.55%1.29K4,007.09%59.06K
-Change in other working capital 243.11%104.66K-86.87%62.93K-4.97%308.55K-447.90%-543.09K96.61%370.6K61.49%-73.13K113.65%479.36K111.16%324.68K335.39%156.11K295.73%188.49K
Cash from discontinued investing activities
Operating cash flow 77.31%-260.56K27.99%-4.76M28.81%-714.88K24.33%-1.25M12.20%-1.64M44.74%-1.15M-9.51%-6.6M33.55%-1M-2.40%-1.65M-59.56%-1.87M
Investing cash flow
Cash flow from continuing investing activities -185.40%-24.11K-2,971.87%-2.49M287.86%33.29K-74,973.70%-2.26M-5,234.66%-261.51K89.68%-8.45K96.23%-81.22K100.94%8.58K99.06%-3.01K99.19%-4.9K
Net PPE purchase and sale ---24.11K-4,023.52%-444.72K-55,655.56%-75K-4,091.21%-108.22K-9,643.11%-261.51K--097.41%-10.79K-99.96%13599.65%-2.58K---2.68K
Net intangibles purchase and sale ------0--0--0--------95.01%-1.94K--086.51%-42690.52%-607
Net business purchase and sale --0-2,893.41%-2.05M1,181.84%108.29K---2.15M--088.79%-8.45K95.97%-68.49K100.58%8.45K--099.82%-1.61K
Cash from discontinued investing activities
Investing cash flow -185.40%-24.11K-2,971.87%-2.49M287.86%33.29K-74,973.70%-2.26M-5,234.66%-261.51K89.68%-8.45K96.23%-81.22K100.94%8.58K99.06%-3.01K99.19%-4.9K
Financing cash flow
Cash flow from continuing financing activities -83.80%527.37K578.31%7.39M-117.69%-141.53K17,753.12%4.45M-169.86K933.34%3.26M-71.10%1.09M-76.48%800K-25.2K0
Net issuance payments of debt -94.97%27.37K108.11%1.66M-117.69%-141.53K--1.45M---190.15K--544K420.00%800K--800K--0--0
Net common stock issuance --01,867.55%5.7M---23.05K11,989.13%3M--20.3K759.89%2.71M-92.06%289.8K--0---25.2K--0
Net preferred stock issuance --500K------------------0----------------
Proceeds from stock option exercised by employees --0--25.43K--23.05K--0---1--2.38K--0--0--0--0
Cash from discontinued financing activities
Financing cash flow -83.80%527.37K578.31%7.39M-117.69%-141.53K17,753.12%4.45M---169.86K933.34%3.26M-71.10%1.09M-76.48%800K---25.2K--0
Net cash flow
Beginning cash position 157.86%232.42K-98.41%90.14K269.46%1.06M-94.27%112.49K-43.01%2.19M-98.41%90.14K-43.70%5.68M-93.94%285.7K-70.46%1.96M-54.41%3.84M
Current changes in cash -88.43%242.7K102.54%142.29K-320.90%-823.12K156.25%943.06K-10.55%-2.08M213.72%2.1M-26.78%-5.59M-120.12%-195.56K13.13%-1.68M-5.48%-1.88M
End cash Position -78.29%475.13K157.86%232.42K157.86%232.42K269.46%1.06M-94.27%112.49K-43.01%2.19M-98.41%90.14K-98.41%90.14K-93.94%285.7K-70.46%1.96M
Free cash flow 72.99%-310.26K21.41%-5.2M21.33%-789.88K17.91%-1.36M-1.59%-1.91M44.91%-1.15M-2.03%-6.62M15.13%-1M29.94%-1.65M-58.97%-1.88M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions --Unqualified Opinion with Explanatory Notes--------Unqualified Opinion with Explanatory Notes------

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
%Chg